Merlonipharma
Managed Access Program & orphan drugs
Hard-to-find, unlicensed, and in-shortage drugs
In urgent need of expedited service?
We can ship Swiss pharmaceutical products within 1 business day of your order.
The latest headlines
- Astellas extends phase III programme for Rydapt rival gilteritinib
- Pfizer-led consortium begins trial of metastatic breast cancer treatment palbociclib
- Grace Century Announces Record ‘All-Time’ Company Enrollment and End of Year Guidance for Its Store-a-Tooth™ Stem Cell Biobank Portfolio Project
- Ironwood’s Duzallo gets FDA approval for gout-associated hyperuricemia
- BIOTRONIK’s Tiny Quadripolar Cardiac Resynchronization Therapy Pacemaker FDA Approved
- Encore makes pipeline play, licensing psoriasis drug from Dr. Reddy’s
- Parexel, Osaka International Cancer Institute combine for Japan trial work
- Microbiome startup Axial gains DepoMed executive as new CMO
- Krystal files for IPO to move gene therapies into clinic
- ViraCyte Announces Positive Phase 2 Trial Results
